Related Experiment Video
Updated: Nov 5, 2025

Modeling Spontaneous Metastatic Renal Cell Carcinoma mRCC in Mice Following Nephrectomy
Published on: April 29, 2014
Agent-Based Learning Model for the Obesity Paradox in RCC
Matteo Belenchia1, Giacomo Rocchetti1, Stefano Maestri1,2
1Laboratory of Data Science and Bioshape, School of Science and Technology, University of Camerino, Camerino, Italy.
Obesity paradox in renal cell carcinoma immunotherapy shows improved outcomes in obese patients. This study uses a computational framework to model cell-cell interactions influencing the tumor microenvironment and immune response.
Area of Science:
- Oncology
- Computational Biology
- Immunology
Background:
- Renal cell carcinoma (RCC) immunotherapy outcomes appear counterintuitively better in obese patients than lean individuals.
- This phenomenon, known as the obesity paradox, is hypothesized to relate to the tumor microenvironment's cell-cell interaction network during immune responses.
Purpose of the Study:
- To develop a computational framework for the in silico study of tumor behavior.
- To investigate the role of cell-cell interaction networks in the tumor microenvironment during immunotherapy for renal cell carcinoma.
Main Methods:
- A multiagent system model was developed to represent the tumor based on its cell-cell interaction network.
- Simulations were performed to generate hypothesized effects of this network on the tumor microenvironment.
Main Results:
- The multiagent system simulation successfully reproduced the dynamics of the cell-cell interaction network.
- The model demonstrated how these interactions can influence the tumor microenvironment in response to simulated environmental changes.
Conclusions:
- The computational framework provides a novel approach to studying tumor behavior in silico.
- This approach can help elucidate the mechanisms behind the obesity paradox in cancer immunotherapy and inform future treatment designs.
More Related Videos
06:38A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
Published on: April 12, 2017
12:22The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers
Published on: January 22, 2013
Related Concept Videos
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
PI3K/mTOR/AKT Signaling Pathway
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution